1 |
Biino, G., Santimone, I., Minelli, C., Sorice, R., Frongia, B., Traglia, M., Ulivi, S., Di Castelnuovo, A., Gogele, M., Nutile, T., Francavilla, M., Sala, C., Pirastu, N., Cerletti, C., Iacoviello, L., Gasparini, P., Toniolo, D., Ciullo, M., Pramstaller, P., Pirastu, M., de Gaetano, G. and Balduini, C. L. 2013. Ageand sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects' data. PLoS One 8, e54289.
DOI
|
2 |
Blennow, K., De Meyer, G., Hansson, O., Minthon, L., Wallin, A., Zetterberg, H., Lewczuk, P., Vanderstichele, H., Vanmechelen, E., Kornhuber, J., Wiltfang, J.; KND-Study Group, Heuser, I., Maier, W., Luckhaus, C., Ruther, E., Hull, M., Jahn, H., Gertz, H. J., Frolich, L., Hampel, H. and Pernetzki, R. 2009. Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment. J. Nutr. Health Aging 13, 205-208.
DOI
|
3 |
Bu, X. L., Xiang, Y., Jin, W. S., Wang, J., Shen, L. L., Huang, Z. L., Zhang, K., Liu, Y. H., Zeng, F., Liu, J. H., Sun, H. L., Zhuang, Z. Q., Chen, S. H., Yao, X. Q., Giunta, B., Shan, Y. C., Tan, J., Chen, X. W., Dong, Z. F., Zhou, H. D., Zhou, X. F., Song, W. and Wang, Y. J. 2018. Blood-derived amyloid-β protein induces Alzheimer's disease pathologies. Mol. Psychiatry 23, 1948-1956.
DOI
|
4 |
Bulbarelli, A., Lonati, E., Brambilla, A., Orlando, A., Cazzaniga, E., Piazza, F., Ferrarese, C., Masserini, M. and Sancini, G. 2012. Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation. Mol. Cell Neurosci. 49, 415-422.
DOI
|
5 |
Buniatian, G. H., Hartmann, H. J., Traub, P., Wiesinger, H., Albinus, M., Nagel, W., Shoeman, R., Mecke, D. and Weser, U. 2002. Glial fibrillary acidic protein-positive cells of the kidney are capable of raising a protective biochemical barrier similar to astrocytes: expression of metallothionein in podocytes. Anat. Rec. 267, 296-306.
DOI
|
6 |
Chen, G. F., Xu, T. H., Yan, Y., Zhou, Y. R., Jiang, Y., Melcher, K. and Xu, H. E. 2017. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol. Sin. 38, 1205-1235.
DOI
|
7 |
Chao, A. C., Lee, T. C., Juo, S. H. and Yang, D. I. 2016. Hyperglycemia increases the production of amyloid beta-peptide leading to decreased endothelial tight junction. CNS Neurosci. Ther. 22, 291-297
DOI
|
8 |
Chen, S. H., Bu, X. L., Jin, W. S., Shen, L. L., Wang, J., Zhuang, Z. Q., Zhang, T., Zeng, F., Yao, X. Q., Zhou, H. D. and Wang, Y. J. 2017. Altered peripheral profile of blood cells in Alzheimer disease: A hospital-based case-control study. Medicine (Baltimore) 96, e6843.
DOI
|
9 |
Chen, M., Inestrosa, N. C., Ross, G. S. and Fernandez, H. L. 1995. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem. Biophys. Res. Commun. 213, 96-103.
DOI
|
10 |
Cheng, Y., Tian, D. Y. and Wang, Y. J. 2020. Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives. Transl. Neurodegener. 9, 16.
DOI
|
11 |
Evin, G. and Li, Q. X. 2012. Platelets and Alzheimer's disease: Potential of APP as a biomarker. World J. Psychiatry 2, 102-113.
DOI
|
12 |
Chouraki, V., Beiser, A., Younkin, L., Preis, S. R., Weinstein, G., Hansson, O., Skoog, I., Lambert, J. C., Au, R., Launer, L., Wolf, P. A., Younkin, S. and Seshadri, S. 2015. Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study. Alzheimers Dement. 11, 249-257.
DOI
|
13 |
Colciaghi, F., Borroni, B., Pastorino, L., Marcello, E., Zimmermann, M., Cattabeni, F., Padovani, A. and Di Luca, M. 2002. α-Secretase ADAM10 as well as αAPPs is reduced in platelets and CSF of Alzheimer disease patients. Mol. Med. 8, 67-74.
DOI
|
14 |
Davies, T. A., Billingslea, A. M., Long, H. J., Tibbles, H., Wells, J. M., Eisenhauer, P. B., Smith, S. J., Cribbs, D. H., Fine, R. E. and Simons, E. R. 1998. Brain endothelial cell enzymes cleave platelet-retained amyloid precursor protein. J. Lab. Clin. Med. 132, 341-350.
DOI
|
15 |
d'Uscio, L. V., He, T. and Katusic, Z. S. 2017. Expression and processing of amyloid precursor protein in vascular endothelium. Physiology (Bethesda) 32, 20-32.
|
16 |
d'Uscio, L. V. and Katusic, Z. S. 2019. Vascular phenotype of amyloid precursor protein-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 316, H1297-H1308.
DOI
|
17 |
Evin, G., Zhu, A., Holsinger, R. M., Masters, C. L. and Li, Q. X. 2003. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets. J. Neurosci. Res. 74, 386-392.
DOI
|
18 |
Fandos, N., Perez-Grijalba, V., Pesini, P., Olmos, S., Bossa, M., Villemagne, V. L., Doecke, J., Fowler, C., Masters, C. L. and Sarasa, M. AIBL Research Group. 2017. Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals. Alzheimers Dement (Amst). 8, 179-187.
DOI
|
19 |
Gowert, N. S., Donner, L., Chatterjee, M., Eisele, Y. S., Towhid, S. T., Munzer, P., Walker, B., Ogorek, I., Borst, O., Grandoch, M., Schaller, M., Fischer, J. W., Gawaz, M., Weggen, S., Lang, F., Jucker, M. and Elvers, M. 2014. Blood platelets in the progression of Alzheimer's disease. PLoS One 9, e90523.
DOI
|
20 |
Graff-Radford, N. R., Crook, J. E., Lucas, J., Boeve, B. F., Knopman, D. S., Ivnik, R. J., Smith, G. E., Younkin, L. H., Petersen, R. C. and Younkin, S. G. 2007. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch. Neurol. 64, 354-362.
DOI
|
21 |
Guest, F. L., Rahmoune, H. and Guest, P. C. 2020. Early diagnosis and targeted treatment strategy for improved therapeutic outcomes in Alzheimer's disease. Adv. Exp. Med. Biol. 1260, 175-191.
DOI
|
22 |
Nayak, M. K., Kulkarni, P. P. and Dash, D. 2013. Regulatory role of proteasome in determination of platelet life span. J. Biol. Chem. 288, 6826-6834.
DOI
|
23 |
McGuinness, B., Fuchs, M., Barrett, S. L., Passmore, A. P. and Johnston, J. A. 2016. Platelet membrane β-secretase activity in mild cognitive impairment and conversion to dementia: a longitudinal study. J. Alzheimers Dis. 49, 1095-1103.
|
24 |
Muche, A., Burger, S., Arendt, T. and Schliebs, R. 2015. Hypoxic stress, brain vascular system, and β-amyloid: a primary cell culture study. Nutr. Neurosci. 18, 1-11.
DOI
|
25 |
Nakamura, A., Kaneko, N., Villemagne, V. L., Kato, T., Doecke, J., Dore, V., Fowler, C., Li, Q. X., Martins, R., Rowe, C., Tomita, T., Matsuzaki, K., Ishii, K., Ishii, K., Arahata, Y., Iwamoto, S., Ito, K., Tanaka, K., Masters, C. L. and Yanagisawa, K. 2018. High performance plasma amyloid-β biomarkers for Alzheimer's disease. Nature 554, 249-254.
DOI
|
26 |
Nguyen, K. V. 2018. Special Issue: Alzheimer's disease. AIMS Neurosci. 5, 74-80.
DOI
|
27 |
Okereke, O. I., Xia, W., Selkoe, D. J. and Grodstein, F. 2009. Ten-year change in plasma amyloid beta levels and late-life cognitive decline. Arch. Neurol. 66, 1247-1253.
DOI
|
28 |
Ovod, V., Ramsey, K. N., Mawuenyega, K. G., Bollinger, J. G., Hicks, T., Schneider, T., Sullivan, M., Paumier, K., Holtzman, D. M., Morris, J. C., Benzinger, T., Fagan, A. M., Patterson, B. W. and Bateman, R. J. 2017. Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimers Dement. 13, 841-849.
DOI
|
29 |
Perez-Grijalba, V., Romero, J., Pesini, P., Sarasa, L., Monleon, I., San-Jose, I., Arbizu, J., Martinez-Lage, P., Munuera, J., Ruiz, A., Tarraga, L., Boada, M. and Sarasa, M. 2019. Plasma Aβ42/40 ratio detects early stages of Alzheimer's disease and correlates with CSF and neuroimaging biomarkers in the AB255 study. J. Prev. Alzheimers Dis. 6, 34-41.
|
30 |
Mantzavinos, V. and Alexiou, A. 2017. Biomarkers for Alzheimer's disease diagnosis. Curr. Alzheimer Res. 14, 1149- 1154.
|
31 |
Roher, A. E., Esh, C. L., Kokjohn, T. A., Castano, E. M., Van Vickle, G. D., Kalback, W. M., Patton, R. L., Luehrs, D. C., Daugs, I. D., Kuo, Y. M., Emmerling, M. R., Soares, H., Quinn, J. F., Kaye, J., Connor, D. J., Silverberg, N. B., Adler, C. H., Seward, J. D., Beach, T. G. and Sabbagh, M. N. 2009. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement. 5, 18-29.
DOI
|
32 |
Santimone, I., Di Castelnuovo, A., De Curtis, A., Spinelli, M., Cugino, D., Gianfagna, F., Zito, F., Donati, M. B., Cerletti, C., de Gaetano, G., Iacoviello, L. and MOLI-SANI Project Investigators. 2011. White blood cell count, sex and age are major determinants of heterogeneity of platelet indices in an adult general population: results from the MOLI-SANI project. Haematologica 96, 1180-1188.
DOI
|
33 |
Schupf, N., Tang, M. X., Fukuyama, H., Manly, J., Andrews, H., Mehta, P., Ravetch, J. and Mayeux, R. 2008. Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 105, 14052-14057.
DOI
|
34 |
Segal, J. B. and Moliterno, A. R. 2006. Platelet counts differ by sex, ethnicity, and age in the United States. Ann. Epidemiol. 16, 123-130.
DOI
|
35 |
Sonkar, V. K., Kulkarni, P. P. and Dash, D. 2014. Amyloid β peptide stimulates platelet activation through RhoA-dependent modulation of actomyosin organization. FASEB J. 28, 1819-1829.
DOI
|
36 |
Sevush, S., Jy, W., Horstman, L. L., Mao, W. W., Kolodny, L. and Ahn, Y. S. 1998. Platelet activation in Alzheimer disease. Arch. Neurol. 55, 530-536.
DOI
|
37 |
Shahpasand-Kroner, H., Klafki, H. W., Bauer, C., Schuchhardt, J., Huttenrauch, M., Stazi, M., Bouter, C., Wirths, O., Vogelgsang, J. and Wiltfang, J. 2018. A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease. Alzheimers Res. Ther. 10, 121.
DOI
|
38 |
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J. and Zlokovic, B. V. 2000. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489-1499.
DOI
|
39 |
Stakos, D. A., Stamatelopoulos, K., Bampatsias, D., Sachse, M., Zormpas, E., Vlachogiannis, N. I., Tual-Chalot, S. and Stellos, K. 2020. The Alzheimer's Disease Amyloid-beta hypothesis in cardiovascular aging and disease: JACC Focus Seminar. J. Am. Coll. Cardiol. 75, 952-967.
|
40 |
Wang, H., Chen, F., Du, Y. F., Long, Y., Reed, M. N., Hu, M., Suppiramaniam, V., Hong, H. and Tang, S. S. 2018. Targeted inhibition of RAGE reduces amyloid-β influx across the blood-brain barrier and improves cognitive deficits in db/db mice. Neuropharmacology 131, 143-153.
DOI
|
41 |
Wang, R. T., Jin, D., Li, Y. and Liang, Q. C. 2013. Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease. J. Psychiatr. Res. 47, 644-649.
DOI
|
42 |
Weller, J. and Budson, A. 2018. Current understanding of Alzheimer's disease diagnosis and treatment. F1000Res. 7, 1161.
DOI
|
43 |
Abdullah, L., Luis, C., Paris, D., Mouzon, B., Ait-Ghezala, G., Keegan, A. P., Wang, D., Crawford, F. and Mullan, M. 2009. Serum Abeta levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT sub-cohort. Mol. Med. 15, 432-437.
DOI
|
44 |
Attems, J., Lintner, F. and Jellinger, K. A. 2004. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathol. 107, 283-291.
DOI
|
45 |
Bermejo-Bescos, P., Martin-Aragon, S., Jimenez-Aliaga, K., Benedi, J., Felici, E., Gil, P., Ribera, J. M. and Villar, A. M. 2013. Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI). Neurochem. Res. 38, 1415-1423.
DOI
|
46 |
Biino, G., Gasparini, P., D'Adamo, P., Ciullo, M., Nutile, T., Toniolo, D., Sala, C., Minelli, C., Gogele, M. and Balduini, C, L. 2012. Influence of age, sex and ethnicity on platelet count in five Italian geographic isolates: mild thrombocytopenia may be physiological. Br. J. Haematol. 157, 384-387.
DOI
|
47 |
Jack, C. R. Jr, Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J. L., Montine, T., Phelps, C., Rankin, K. P., Rowe, C. C., Scheltens, P., Siemers, E., Snyder, H. M. and Sperling, R. 2018. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 14, 535-562.
DOI
|
48 |
Wolk, D. A., Grachev, I. D., Buckley, C., Kazi, H., Grady, M. S., Trojanowski, J. Q., Hamilton, R. H., Sherwin, P., McLain, R. and Arnold, S. E. 2011. Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology. Arch. Neurol. 68, 1398-1403.
DOI
|
49 |
Hampel, H., O'Bryant, S. E., Molinuevo, J. L., Zetterberg, H., Masters, C. L., Lista, S., Kiddle, S. J., Batrla, R. and Blennow, K. 2018. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat. Rev. Neurol. 14, 639-652.
DOI
|
50 |
Inyushin, M. Y., Sanabria, P., Rojas, L., Kucheryavykh, Y. and Kucheryavykh, L. 2017. Aβ peptide originated from platelets promises new strategy in anti-Alzheimer's drug development. Biomed. Res. Int. 2017, 3948360.
|
51 |
Kelley, M., Ulin, B. and McGuire, L. C. 2018. Reducing the risk of Alzheimer's disease and maintaining brain health in an aging society. Public Health Rep. 133, 225-229.
DOI
|
52 |
Li, R., Hoffmeister, K. M. and Falet, H. 2016. Glycans and the platelet life cycle. Platelets 27, 505-511.
DOI
|
53 |
Kim, H. J., Park, K. W., Kim, T. E., Im, J. Y., Shin, H. S., Kim, S., Lee, D. H., Ye, B. S., Kim, J. H., Kim, E. J., Park, K. H., Han, H. J., Jeong, J. H., Choi, S. H. and Park, S. A. 2015. Elevation of the plasma Aβ40/Aβ42 ratio as a diagnostic marker of sporadic early-onset Alzheimer's disease. J. Alzheimers Dis. 48, 1043-1050.
DOI
|
54 |
Koc, E. R., Uzar, E., Cirak, Y., Parlak Demir, Y. and Ilhan, A. 2014. The increase of mean platelet volume in patients with Alzheimer disease. Turk. J. Med. Sci. 44, 1060-1066.
DOI
|
55 |
Korniluk, A., Koper-Lenkiewicz, O. M., Kaminska, J., Kemona, H. and Dymicka-Piekarska, V. 2019. Mean Platelet Volume (MPV): New perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators Inflamm. 2019, 9213074.
DOI
|
56 |
Koyama, A., Okereke, O. I., Yang, T., Blacker, D., Selkoe, D. J. and Grodstein, F. 2012. Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis. Arch. Neurol. 69, 824-831.
|
57 |
Kukull, W. A. and Bowen, J. D. 2002. Dementia epidemiology. Med. Clin. North Am. 86, 573-590.
DOI
|
58 |
Lambert, J. C., Schraen-Maschke, S., Richard, F., Fievet, N., Rouaud, O., Berr, C., Dartigues, J. F., Tzourio, C., Alperovitch, A., Buee, L. and Amouyel, P. 2009. Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology 73, 847-853.
DOI
|
59 |
Lewczuk, P. and Kornhuber, J. 2016. Do we still need positron emission tomography for early Alzheimer's disease diagnosis? Brain 139, e60.
DOI
|
60 |
Li, Q. X., Whyte, S., Tanner, J. E., Evin, G., Beyreuther, K. and Masters, C. L. 1998. Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets. Lab. Invest. 78, 461-469.
|
61 |
Liang, Q. C., Jin, D., Li, Y. and Wang, R. T. 2014. Mean platelet volume and platelet distribution width in vascular dementia and Alzheimer's disease. Platelets 25, 433-438.
DOI
|
62 |
Liu, W. W., Todd, S., Coulson, D. T., Irvine, G. B., Passmore, A. P., McGuinness, B., McConville, M., Craig, D. and Johnston, J. A. 2009. A novel reciprocal and biphasic relationship between membrane cholesterol and beta-secretase activity in SH-SY5Y cells and in human platelets. J. Neurochem. 108, 341-249.
DOI
|
63 |
Liu, W. W., Todd, S., Craig, D., Passmore, A. P., Coulson, D. T., Murphy, S., Irvine, G. B. and Johnston, J. A. 2007. Elevated platelet beta-secretase activity in mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 24, 464-468.
DOI
|
64 |
DeKosky, S. T. and Marek, K. 2003. Looking backward to move forward: early detection of neurodegenerative disorders. Science 302, 830-834.
DOI
|
65 |
Davies, T. A., Long, H. J., Sgro, K., Rathbun, W. H., Mc Menamin, M. E., Seetoo, K., Tibbles, H., Billingslea, A. M., Fine, R. E., Fishman, J. B., Levesque, C. A., Smith, S. J., Wells, J. M. and Simons, E. R. 1997. Activated Alzheimer disease platelets retain more beta amyloid precursor protein. Neurobiol. Aging 18, 147-153.
DOI
|
66 |
Deane, R., Bell, R. D., Sagare, A. and Zlokovic, B. V. 2009. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 8, 16-30.
DOI
|
67 |
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., Zhu, H., Ghiso, J., Frangione, B., Stern, A., Schmidt, A. M., Armstrong, D. L., Arnold, B., Liliensiek, B., Nawroth, P., Hofman, F., Kindy, M., Stern, D. and Zlokovic, B. 2003. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9, 907-913.
DOI
|
68 |
DeMattos, R. B., Bales, K. R., Parsadanian, M., O'Dell, M. A., Foss, E. M., Paul, S. M. and Holtzman, D. M. 2002. Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease. J. Neurochem. 81, 229-236.
DOI
|
69 |
Do, T. M., Dodacki, A., Alata, W., Calon, F., Nicolic, S., Scherrmann, J. M., Farinotti, R. and Bourasset, F. 2016. Age-dependent regulation of the blood-brain barrier influx/efflux equilibrium of amyloid-β peptide in a mouse model of Alzheimer's disease (3xTg-AD). J. Alzheimers Dis. 49, 287-300.
|
70 |
Dong, X., Nao, J., Shi, J. and Zheng, D. 2019. Predictive value of routine peripheral blood biomarkers in Alzheimer's disease. Front. Aging Neurosci. 11, 332.
DOI
|
71 |
Van Nostrand, W. E., Schmaier, A. H., Farrow, J. S. and Cunningham, D. D. 1990. Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein. Science 248, 745-748.
DOI
|
72 |
Seppala, T. T., Nerg, O., Koivisto, A. M., Rummukainen, J., Puli, L., Zetterberg, H., Pyykko, O. T., Helisalmi, S., Alafuzoff, I., Hiltunen, M., Jaaskelainen, J. E., Rinne, J., Soininen, H., Leinonen, V. and Herukka, S. K. 2012. CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings. Neurology 78, 1568-1575.
DOI
|
73 |
Stevens, R. F. and Alexander, M. K. 1977. A sex difference in the platelet count. Br. J. Haematol. 37, 295-300.
DOI
|
74 |
Tang, K., Hynan, L. S., Baskin, F. and Rosenberg, R. N. 2006. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease. J. Neurol. Sci. 240, 53-58.
DOI
|